Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Double Blind Dose Finding Trial of Bupropion Versus Placebo for Sexual Desire in Women With Breast or Gynecologic Cancer

NCT03180294 is registered in ClinicalTrials.gov with NRG Oncology as lead sponsor.

NCT NCT03180294
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03180294 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Double Blind Dose Finding Trial of Bupropion Versus Placebo for Sexual Desire in Women With Breast or Gynecologic Cancer
Lead sponsor
NRG Oncology
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2017
Completion date
February 22, 2021
Enrollment
230 (actual)
Sites
362

Conditions

As the registry lists them; a condition with its own page is linked.

breast carcinoma, cervical carcinoma, ovarian carcinoma, postmenopausal, uterine corpus cancer, vaginal carcinoma, vulvar carcinoma